Clinical relevance of biomarkers in heart failure and cardiorenal syndrome: the role of natriuretic peptides and troponin (Q38096829)

28 August 2017

title

Clinical relevance of biomarkers in heart failure and cardiorenal syndrome: the role of natriuretic peptides and troponin (English)

1 reference

28 August 2017

0 references

0 references

1 reference

Claudio Ronco

1 reference

28 August 2017

Alberto Palazzuoli

1 reference

28 August 2017

Serge Masson

series ordinal

1 reference

28 August 2017

Alan Maisel

series ordinal

1 reference

28 August 2017

publication date

1 March 2014

1 reference

28 August 2017

published in

Heart Failure Reviews

1 reference

28 August 2017

1 reference

28 August 2017

1 reference

28 August 2017

page(s)

267-284

1 reference

Acute heart failure syndromes

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Sympathetic nervous system activation in human heart failure: clinical implications of an updated model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Neurohormonal inhibition in heart failure: insights from recent clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Renal impairment and outcomes in heart failure: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Biomarkers in kidney and heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Biomarkers in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Natriuretic peptides--relevance in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Biomarkers in acute heart failure--state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Natriuretic peptides in heart failure: where we are, where we are going.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Recommendations for the use of natriuretic peptides in acute cardiac care: A position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

BNP at discharge in acute heart failure patients: is it all about volemia? A study using impedance cardiography to assess fluid and hemodynamic status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Correlation Between NT-pro BNP levels and left ventricular wall stress, sphericity index and extent of myocardial damage: a magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Predictive value of NT-pro BNP after acute myocardial infarction: relation with acute and chronic infarct size and myocardial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Myocardial tissue troponins T and I. An immunohistochemical study in experimental models of myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Isoproterenol-induced cardiotoxicity in sprague-dawley rats: correlation of reversible and irreversible myocardial injury with release of cardiac troponin T and roles of iNOS in myocardial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Gender differences and aging: effects on the human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Troponin elevation in coronary vs. non-coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Relationship between renal function and serum cardiac troponin T in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Comparison of peak exercise oxygen uptake in men versus women in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Prediction of outcome by highly sensitive troponin T in outpatients with chronic systolic left ventricular heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

High sensitive troponin T and heart fatty acid binding protein: Novel biomarker in heart failure with normal ejection fraction?: A cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Serial changes in high‐sensitive troponin I predict outcome in patients with decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Cardiac troponin and outcome in acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Sensitive cardiac troponin in the diagnosis and risk stratification of acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Prognostic value of serial measurements of highly sensitive cardiac troponin I in stable outpatients with nonischemic chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Renal function, neurohormonal activation, and survival in patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Epidemiology and outcome of the cardio-renal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

The cardiorenal syndrome in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Cardiorenal syndrome in decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Worsening renal function and prognosis in heart failure: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Estimating kidney function in adults using formulae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Laboratory parameters of cardiac and kidney dysfunction in cardio-renal syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Influence of renal dysfunction phenotype on mortality in the setting of cardiac dysfunction: analysis of three randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Emergence of blood urea nitrogen as a biomarker of neurohormonal activation in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Chronic kidney disease: effects on the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Albuminuria in chronic heart failure: prevalence and prognostic importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Prevalence and prognostic value of elevated urinary albumin excretion in patients with chronic heart failure: data from the GISSI-Heart Failure trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Prognostic utility of plasma neutrophil gelatinase‐associated lipocalin in patients with acute heart failure: The NGAL EvaLuation Along with B‐type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in patients with chronic heart failure and coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Neutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardio-renal syndrome in the general ward.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Early detection of acute renal failure by serum cystatin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Prognostic value of cystatin C on admission in heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Clinical outcome of renal tubular damage in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Role of biomarkers in the diagnosis and management of cardio-renal syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Outcomes following oesophagectomy in patients with oesophageal cancer: a secondary analysis of the ICNARC Case Mix Programme Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Cardiac troponins in renal insufficiency: review and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Over time, high-sensitivity TnT replaces NT-proBNP as the most powerful predictor of death in patients with dialysis-dependent chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Troponin I as a prognostic marker of cardiac events in asymptomatic hemodialysis patients using a sensitive troponin I assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

FGF23 induces left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Biomarkers as surrogate end points in heart failure trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Multiple biomarkers for risk prediction in chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Prognostic value of troponin and creatine kinase muscle and brain isoenzyme measurement after noncardiac surgery: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Prognostic value of cardiac troponin in chronic stable heart failure: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Predictors of mortality in 6975 patients with chronic heart failure in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure trial: proposal for a nomogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are useful in heart failure management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are not useful in heart failure management: the art of medicine remains long

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Prognostic value of biomarkers in heart failure: application of novel methods in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Definition and classification of Cardio-Renal Syndromes: workgroup statements from the 7th ADQI Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9391-X

Clinical significance of cardiac troponins I and T in acute heart failure

21 January 2018

1 reference

12 December 2020

Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure

1 reference

12 December 2020

1 reference

12 December 2020

Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury

1 reference

12 December 2020

Brain natriuretic peptide levels have diagnostic and prognostic capability for cardio-renal syndrome type 4 in intensive care unit patients

1 reference

12 December 2020

Interpreting cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome

1 reference

12 December 2020

What is the role of serial high-sensitivity troponin measurements in chronic heart failure?

1 reference

12 December 2020

Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.

1 reference

12 December 2020

Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T

1 reference

12 December 2020

Clinical impact of renal dysfunction in heart failure.

1 reference

12 December 2020

Association between fibroblast growth factor 23 and left ventricular hypertrophy in maintenance hemodialysis patients. Comparison with B-type natriuretic peptide and cardiac troponin T

1 reference

12 December 2020

Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial)

1 reference

12 December 2020

Circulating Cardiac Troponin I in Severe Congestive Heart Failure

1 reference

12 December 2020

Cardiac troponins and renal function in nondialysis patients with chronic kidney disease

1 reference

12 December 2020

Cardiac troponin I concentration is commonly increased in nondialysis patients with CKD: experience with a sensitive assay

1 reference

12 December 2020

Highly sensitive troponin T for risk stratification of acutely destabilized heart failure

1 reference

12 December 2020

Detectable serum troponin I in patients with heart failure of nonmyocardial ischemic origin

1 reference

12 December 2020

FGF-23 is associated with cardiac troponin T and mortality in hemodialysis patients

1 reference

12 December 2020

Clinical characteristics and predictors of in-hospital mortality in acute heart failure with preserved left ventricular ejection fraction

1 reference

12 December 2020

Prognostic value of highly sensitive troponin T on cardiac events in patients with chronic kidney disease not on dialysis

1 reference

12 December 2020

Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure

1 reference

12 December 2020

10.1007/S10741-013-9391-X

Identifiers

DOI

1 reference

28 August 2017

1 reference